02/29/2024 8:54 PM | BP Directors, LP (Reporting) Cavu Advisors, LLC (Reporting) Cavu Management, LP (Reporting) Kreis Leslie W. (Reporting) Lantern Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 8:54 PM | BIOS Advisors GP, LLC (Reporting) BIOS Capital Management, LP (Reporting) Bios Equity Partners II, LP (Reporting) Bios Equity Partners, LP (Reporting) BIOS Fund I QP, LP (Reporting) BIOS Fund I, LP (Reporting) BIOS Fund II NT, LP (Reporting) BIOS Fund II QP, LP (Reporting) BIOS Fund II, LP (Reporting) Fletcher Aaron G.L. (Reporting) Lantern Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:40 PM | BIOS Fund II, LP (Reporting) Lantern Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 8:41 PM | BIOS Fund II NT, LP (Reporting) Lantern Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 8:41 PM | BIOS Fund II QP, LP (Reporting) Lantern Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 3:30 PM | BP Directors, LP (Reporting) Cavu Advisors, LLC (Reporting) Cavu Management, LP (Reporting) Kreis Leslie W. (Reporting) Lantern Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:31 PM | BIOS Advisors GP, LLC (Reporting) BIOS Capital Management, LP (Reporting) Bios Equity Partners II, LP (Reporting) Bios Equity Partners, LP (Reporting) BIOS Fund I QP, LP (Reporting) BIOS Fund I, LP (Reporting) BIOS Fund II NT, LP (Reporting) BIOS Fund II QP, LP (Reporting) BIOS Fund II, LP (Reporting) Fletcher Aaron G.L. (Reporting) Lantern Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 5:00 AM | BP Directors, LP (Reporting) Cavu Advisors, LLC (Reporting) Cavu Management, LP (Reporting) Kreis Leslie W. (Reporting) Lantern Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 5:01 AM | BIOS Advisors GP, LLC (Reporting) BIOS Capital Management, LP (Reporting) Bios Equity Partners II, LP (Reporting) Bios Equity Partners, LP (Reporting) BIOS Fund I QP, LP (Reporting) BIOS Fund I, LP (Reporting) BIOS Fund II NT, LP (Reporting) BIOS Fund II QP, LP (Reporting) BIOS Fund II, LP (Reporting) Fletcher Aaron G.L. (Reporting) Lantern Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 5:02 AM | Bios Equity Partners, LP (Filed by) Lantern Pharma (Subject)
| Form SC 13D/A | |
11/24/2023 3:05 PM | Lantern Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2023 4:25 PM | Lantern Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2023 3:05 PM | Lantern Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/05/2023 8:35 AM | Lantern Pharma (Filer)
| Form ARS | |